{
    "name": "Omnichannel Gardasil Q4 2022_Study Future Pre-Vulva Cancer_Automation",
    "description": "",
    "key": "55d2bd6b-5cb9-4e58-98bc-be7b550de989",
    "type": "scheduled",
    "status": "Ready",
    "schedule": {
        "startDate": "2023-01-23T15:00:00",
        "endDate": "2023-01-23T15:00:00",
        "icalRecur": "FREQ=DAILY;COUNT=1;INTERVAL=1",
        "timezoneName": "SE Asia Standard Time"
    },
    "steps": [
        {
            "name": "",
            "activities": [
                {
                    "name": "Omnichannel Gardasil Q4 2022_Study Future Pre-Vulva Cancer_Veeva",
                    "r__type": "query"
                }
            ]
        },
        {
            "name": "",
            "activities": [
                {
                    "name": "Omnichannel Gardasil Q4 2022_Study Future Pre-Vulva Cancer_Veeva",
                    "r__type": "filter"
                }
            ]
        },
        {
            "name": "",
            "activities": [
                {
                    "name": "Omnichannel Gardasil Q4 2022_Study Future Pre-Vulva Cancer_CRM",
                    "r__type": "query"
                }
            ]
        },
        {
            "name": "",
            "activities": [
                {
                    "name": "Omnichannel Gardasil Q4 2022_Study Future Pre-Vulva Cancer_CRM",
                    "r__type": "filter"
                }
            ]
        }
    ],
    "r__folder_Path": "my automations"
}
